🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tamoxifen is a potent and effective drug reducing the risk of dying from br...
Status
Unknown
Location
Karolinska University Hospital
Start Date
2022-04-04
Trial ID
NCT05133674
Treatments Being Tested
This randomized phase IIB trial studies how well tamoxifen or afimoxifene w...
Status
Completed
Location
Northwestern University
Start Date
2017-05-31
Trial ID
NCT02993159
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of two doses of 4-hyd...
Status
Completed
Location
Multiple Locations
Start Date
2003-03
Trial ID
NCT00272714
Treatments Being Tested
The investigators plan to prospectively study breast tissue changes after a...
Status
Terminated
Location
Northwestern University
Start Date
2021-07-26
Trial ID
NCT04570956
This randomized phase II trial studies how well afimoxifene works in reduci...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2018-01-30
Trial ID
NCT03063619
Treatments Being Tested
RATIONALE: High estrogen levels may be associated with dense breast tissue ...
Status
Completed
Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Start Date
2003-04
Trial ID
NCT00084344
Treatments Being Tested
This phase II trial studies how well topical afimoxifene works in treating ...
Status
Active Not Recruiting
Location
Northwestern University
Start Date
2020-02-17
Trial ID
NCT04009044
Treatments Being Tested
This randomized phase II trial is studying 4-hydroxytamoxifen to see how we...
Status
Completed
Location
Northwestern University
Start Date
2009-12
Trial ID
NCT00952731
Treatments Being Tested
SAKK 21/12 is a stratified, multicenter Phase II first in-human trial with ...
Status
Terminated
Location
Kantonsspital Aarau
Start Date
2016-06-14
Trial ID
NCT02067741
Treatments Being Tested
A study to determine the efficacy of 8 mg/day (4 mg/breast) of BHR-700 gel ...
Status
Terminated
Location
Mesa Obstetricians and Gynecologists/Cactus Clinical Research
Start Date
2017-08-21
Trial ID
NCT03199963
Treatments Being Tested